P H A R M A C O L O G Y F O R T H E N C L E X - R N MUST KNOW DRUGS

Document Content and Description Below

• MOA –thrombolytic – plasminogen activator – • Indications –MI –Acute ischemic stroke –Occluded Central lines • Nursing Considerations –Contraindicated in active bleeding –... Monitor for active bleeding (q15m x 1hr; q15-30m x 8hr) –May cause intracranial hemorrhage –Monitor for anaphylaxis –Use caution with uncontrolled hypertension –Assess neuro status during therapy •A patient is admitted to the emergency department with chest pain. An electrocardiogram shows changes consistent with an evolving myocardial infarction. The patient’s cardiac enzymes are pending. The nurse caring for this patient will expect to: A. administer aspirin when cardiac enzymes are completed. B. give alteplase [Activase] within 2 hours. C. give tenecteplase [TNKase] immediately. D. obtain an order for an INR. A patient is admitted to the emergency department with chest pain. An electrocardiogram shows changes consistent with an evolving myocardial infarction. The patient’s cardiac enzymes are pending. The nurse caring for this patient will expect to: A. administer aspirin when cardiac enzymes are completed. B. give alteplase [Activase] within 2 hours. C. give tenecteplase [TNKase] immediately. D. obtain an order for an INR. ATORVASTATIN • MOA –HMG-CoA reductase inhibitor – lipid lowering agent – • [Show More]

Last updated: 1 year ago

Preview 1 out of 63 pages